Scenario Analyses of Lifetime Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT
May 16th, 2020
Patient-Reported Outcomes, Resource Utilization, and Health Care Expenditures Across the 3 Major Atherosclerotic Diseases
May 16th, 2020
Impacts of the Million Hearts® Cardiovascular Disease Risk Reduction Model on the Initiation or Intensification of Statins and Anti-Hypertensive Medications
May 16th, 2020
Social Determinants of Health and Participant Retention in a Disparities Study and Primary Care
May 16th, 2020
Patient-Reported Versus Physician-Estimated Angina in Patients Undergoing PCI
May 16th, 2020
5 Early Career Investigator Award Finalists
May 15th, 2020
A Novel Risk Tool to Predict Chronic Stress in Patients With Cardiovascular Disease
May 15th, 2020
Population-Level Insights Into 30-Day Mortality in Medicare Beneficiaries After Inpatient and Outpatient Catheter Ablation for Atrial Fibrillation
May 15th, 2020
Prevalence and Prognostic Significance of Aortic Stenosis in Patients With Acute Decompensated Heart Failure
May 15th, 2020
Protecting Medical Trainees on the COVID-19 Frontlines Saves Us All
Apr 6th, 2020